CALM
Cal-Maine Foods, Inc.
CALM trails on the overall score without a compensating advantage in the available component scores.
CELH
Celsius Holdings, Inc.
CELH has the edge over CALM overall, supported by stronger fundamentals and stronger modeled upside.
CALM Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Under pressure | |
| Under pressure | |
| Strong |
CALM's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
CALM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.7x | $4.59 | -93% |
| Fair | 10x | $12.73 | -80% |
| Expensive | 51x | $63.59 | -0.9% |
| Current | 51x | $64.18 | — |
Historical ranges are pointers, not guarantees.
CALM's PE is in its expensive range at 51x.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over CALM in the historical PE scenario, which offers more potential upside but is not a forecast.
CALM Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect CALM's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over CALM on the outlook, with more favorable earnings and revenue expectations.
CALM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.25 | -95% |
| Q2 2026 | $6.63 | -73% |
| Q1 2026 | $14.35 | -29% |
| Q4 2025 | $23.67 | +84% |
| Q3 2025 | $26.01 | +198% |
| Q2 2025 | $24.95 | +338% |
| Q1 2025 | $20.23 | +259% |
| Q4 2024 | $12.85 | +39% |
CALM has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
CALM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $539.6M | -42% |
| Q2 2026 | $552.6M | -50% |
| Q1 2026 | $667M | -53% |
| Q4 2025 | $769.5M | -19% |
| Q3 2025 | $922.6M | +17% |
| Q2 2025 | $1.1B | +72% |
| Q1 2025 | $1.4B | +102% |
| Q4 2024 | $954.7M | +82% |
CALM's revenue has slid since its 2025 peak: $540M last quarter, down 42% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -15% | -42 points |
| Q2 2026 | -11% | -50 points |
| Q1 2026 | 5.4% | -40 points |
| Q4 2025 | 16% | -13 points |
| Q3 2025 | 27% | +3.2 points |
| Q2 2025 | 39% | +17 points |
| Q1 2025 | 45% | +22 points |
| Q4 2024 | 29% | +26 points |
CALM's operating margin was −15% last quarter, down 42 points from the same quarter a year ago, near the bottom of its range since 2019.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over CALM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over CALM on profitability, with a higher operating margin.
CALM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$128M | -155% |
| Q2 2026 | -$24.7M | -107% |
| Q1 2026 | $72M | -86% |
| Q4 2025 | $47.9M | -48% |
| Q3 2025 | $233.3M | +186% |
| Q2 2025 | $367.1M | +126% |
| Q1 2025 | $521.8M | +290% |
| Q4 2024 | $92.9M | +755% |
CALM's free cash flow was −$33M over the past year, against $1.2B the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over CALM on cash generation, producing positive trailing cash flow while its opponent burns cash.
CALM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.3% | -1.1M shares |
| 1 year | -3.6% | -1.7M shares |
| 3 years | -4.4% | -2.1M shares |
| 5 years | -4.4% | -2.2M shares |
| Available history | -3.6% | -1.7M shares |
CALM has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | $826,000 |
| Q4 2020 | $45,000 |
| Q3 2020 | — |
| Q1 2020 | $889,000 |
| Q4 2019 | $10,000 |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
CALM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -0.2x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.2x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
CALM has the edge over CELH on leverage, with a lower net debt burden relative to earnings.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
CALM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 13.1 | Oversold |
CALM's weekly RSI is 31 (neutral) and its Stochastic is 13 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
CALM PE vs Consumer Defensive Sector
| Metric | CALM | Sector median | Relative |
|---|---|---|---|
| PE | 51x | 19x | 163% above |
| PE % | 84 | 18 | 66 pts above |
CALM is trading at 51x earnings, a 163% premium to the Consumer Defensive sector's median of 19x.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over CALM on valuation relative to its sector.
CALM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $64.6 | 0.7% below |
| 20 week MA | $75.3 | 15% below |
| 50 week MA | $78.2 | 18% below |
| 100 week MA | $88.4 | 27% below |
| 200 week MA | $74.0 | 13% below |
CALM is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has the edge over CALM on trend strength, trading above more of its moving averages.
CALM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.0 | $37.4 | -13% |
| 2021 | $37.4 | $36.5 | -2.3% |
| 2022 | $36.5 | $64.6 | +77% |
| 2023 | $64.6 | $57.4 | -11% |
| 2024 | $57.4 | $101.1 | +76% |
| 2025 | $101.1 | $82.0 | -19% |
| 2026 YTD | $82.0 | $64.2 | -22% |
CALM has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.